Educational articles and laboratory guides on retatrutide research — written and reviewed by our editorial team. Strictly informational; not medical advice.
FEATURED · RESEARCH
A researcher's overview of how retatrutide is designed to engage GLP-1, GIP and glucagon receptors simultaneously, and why that makes it a focus of ongoing investigational study.
Research
Retatrutide has attracted considerable attention in metabolic research because it does something unusual: a single molecule is designed to activate three different…
Retatrutide
Retatrutide is one of the most closely watched investigational medicines in metabolic research. Developed by Eli Lilly and Company, it belongs to…
Retatrutide
Retatrutide is now one of the most commonly talked about peptides in metabolism studies. But for the uninitiated, concepts such as reconstitution,…
Retatrutide
Where the retatrutide Phase 3 TRIUMPH programme stands in 2026, what TRIUMPH-4 and TRANSCEND-T2D-1 reported, which trials are still running and the expected regulatory timeline.
Clinical Studies
What the landmark NEJM Phase 2 obesity trial found about retatrutide: weight-loss results at 24 and 48 weeks, cardiometabolic findings, side effects and the study limitations researchers flagged.
Clinical Studies
What purity, identity and method columns actually tell you about a batch.
Research
An overview of receptor-binding assays used across metabolic peptide research.
Laboratory Guides
Bacteriostatic water ratios, sterile technique and common handling errors to avoid.
Research
Practical guidance on storing and transporting research peptides.
Retatrutide
From molecular discovery to large-scale investigational programmes.
Laboratory Guides
Linking batch numbers, COAs and lab notes for reproducible work.